Literature DB >> 9103509

Neuropeptide Y-mediated pressor responses following high-frequency stimulation of the rat sympathetic nervous system.

B Kennedy1, G H Shen, M G Ziegler.   

Abstract

Neuropeptide Y (NPY) is a potent pressor agent that is stored in the sympathetic nerves. In several species, NPY release is augmented when sympathetic impulse frequencies increase. We investigated the extent to which NPY contributes to the pressor response to high- and low-frequency electrical stimulation. Rats were pithed, and the sympathetic trunk was stimulated at either 20 or 3 Hz in the presence or absence of antagonists of NPY and alpha and beta adrenergic receptors. The 20-Hz stimulation raised plasma NPY levels, but the 3-Hz stimulation did not. The 20-Hz stimulation caused marked pressor responses that were maintained for several minutes after the end of stimulation regardless of whether rats were pretreated with adrenergic blockers. The NPY antagonists BIBP 3226 and 1229U91 reduced the size of the pressor response that followed 20 Hz stimulation by >50%. The rapid blood pressure spikes that occur during electrical stimulation are attenuated by alpha adrenergic but not by NPY antagonists. There is a prolonged pressor response after high-frequency stimulation of the sympathetic trunk in pithed rats that begins after 1 to 2 min of stimulation and lasts approximately 10 min after the end of stimulation. At least half of this pressor response is mediated by NPY.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9103509

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Effects of a selective neuropeptide Y Y(1) receptor antagonist BIBP 3226 on double peaked vasoconstrictor responses to periarterial nerve stimulation in canine splenic arteries.

Authors:  X P Yang; S Chiba
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

Review 2.  Neuropeptide Y in the recurrent mossy fiber pathway.

Authors:  J Victor Nadler; Bin Tu; Olga Timofeeva; Yiqun Jiao; Herbert Herzog
Journal:  Peptides       Date:  2007-01-03       Impact factor: 3.750

Review 3.  Neuronal and non-neuronal modulation of sympathetic neurovascular transmission.

Authors:  H Macarthur; G H Wilken; T C Westfall; L L Kolo
Journal:  Acta Physiol (Oxf)       Date:  2011-03-01       Impact factor: 6.311

4.  Enhanced neuropeptide Y synthesis during intermittent hypoxia in the rat adrenal medulla: role of reactive oxygen species-dependent alterations in precursor peptide processing.

Authors:  Gayatri Raghuraman; Apeksha Kalari; Rishi Dhingra; Nanduri R Prabhakar; Ganesh K Kumar
Journal:  Antioxid Redox Signal       Date:  2011-02-06       Impact factor: 8.401

5.  Neuropeptide Y(1) Receptor NPY1R discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo.

Authors:  Lei Wang; Fangwen Rao; Kuixing Zhang; Manjula Mahata; Juan L Rodriguez-Flores; Maple M Fung; Jill Waalen; Myles G Cockburn; Bruce A Hamilton; Sushil K Mahata; Daniel T O'Connor
Journal:  J Am Coll Cardiol       Date:  2009-09-01       Impact factor: 24.094

6.  Cardiovascular responses to electrical stimulation of sympathetic nerves in the pithed mouse.

Authors:  Hamzeh H Elayan; Ping Sun; Milos Milic; Fujun Liu; Xuping Bao; Michael G Ziegler
Journal:  Auton Neurosci       Date:  2008-04-14       Impact factor: 3.145

7.  Cathepsin L participates in the production of neuropeptide Y in secretory vesicles, demonstrated by protease gene knockout and expression.

Authors:  Lydiane Funkelstein; Thomas Toneff; Shin-Rong Hwang; Thomas Reinheckel; Christoph Peters; Vivian Hook
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

8.  Contribution of Baroreflex Afferent Pathway to NPY-Mediated Regulation of Blood Pressure in Rats.

Authors:  Yang Liu; Shu-Yang Zhao; Yan Feng; Jie Sun; Xiao-Long Lu; Qiu-Xin Yan; Ying Li; Zhuo Liu; Lu-Qi Wang; Xun Sun; Shijun Li; Guo-Fen Qiao; Bai-Yan Li
Journal:  Neurosci Bull       Date:  2019-10-29       Impact factor: 5.203

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.